Secondary solid malignancies after high-grade glioma treatment in pediatric patients

Due to the poor survival in high-grade glioma (HGG), secondary solid malignancies (SSM) following pediatric HGG are scarce. The authors present the experience from the HIT-HGG database in Germany, Austria, and Switzerland. Five out of 1228 pediatric HGG patients developed a SSM following a latency o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: Karremann, Michael (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 03 Aug 2015
In: Pediatric hematology and oncology
Year: 2015, Jahrgang: 32, Heft: 7, Pages: 467-473
ISSN:1521-0669
DOI:10.3109/08880018.2015.1050615
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.3109/08880018.2015.1050615
Verlag, Volltext: https://doi.org/10.3109/08880018.2015.1050615
Volltext
Verfasserangaben:Michael Karremann, Marion Hoffmann, Martin Benesch, Robert Kwiecien, André O. von Bueren, and Christof M. Kramm
Beschreibung
Zusammenfassung:Due to the poor survival in high-grade glioma (HGG), secondary solid malignancies (SSM) following pediatric HGG are scarce. The authors present the experience from the HIT-HGG database in Germany, Austria, and Switzerland. Five out of 1228 pediatric HGG patients developed a SSM following a latency of 29-122 months from primary HGG diagnosis. In 4 patients, the SSM may be attributed to previous radiotherapy or a tumor predisposition syndrome, reflected by a markedly increased cumulative incidence rate of SSM in patients with tumor predisposition. Survival was devastating, since none of the patients survived beyond 18 months from SSM diagnosis.
Beschreibung:Gesehen am 01.02.2018
Beschreibung:Online Resource
ISSN:1521-0669
DOI:10.3109/08880018.2015.1050615